Mapp Biopharmaceutical (United States)

Recent papers from Mapp Biopharmaceutical (United States)

1. Stakeholder-informed use cases and target product characteristics for vaccines and therapeutics for Nipah virus diseasenpj Vaccines · 2026
2. Encephalitic alphavirus infection induces long-term humoral and cell-mediated responses in seropositive participants from PanamaPLoS neglected tropical diseases · 2026
3. Recombinant Bombali ebolavirus in cynomolgus macaques as a survival model of Ebola virus diseaseNature Communications · 2026
4. Abstract 4593: PBI-381, a development candidate PROTAC for KRasG12D solid tumorsCancer Research · 2026
5. P-1186. Pharmacodynamic Assessment of Combination of Cefiderocol with Xeruborbactam in Murine Thigh Infection ModelOpen Forum Infectious Diseases · 2026
6. Engineering Native-like GPCR Antigens Enables Discovery of an LPA2-Blocking Antibody for Ovarian CancerACS Synthetic Biology · 2025
7. Comparison of Landfill Methane Emission Quantification Using Multiple Observation MethodsACS ES&T Air · 2025
8. Avidity and variable domain spacing strongly influence the therapeutic potency of bispecific antibodies against Crimean-Congo hemorrhagic fever virusmBio · 2025
9. Performance of Airborne Imaging Spectrometers for Carbon Dioxide Detection and Emission QuantificationJournal of Geophysical Research Atmospheres · 2025
10. Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spreadScience Translational Medicine · 2025
11. Comparing Point Source CO ₂ Emission Rate Estimates From Near‐Simultaneous OCO‐3 and EMIT ObservationsGeophysical Research Letters · 2024
12. Probability of Detection and Multi-Sensor Persistence of Methane Emissions from Coincident Airborne and Satellite ObservationsEnvironmental Science & Technology · 2024
13. A Longitudinal Analysis of Memory Immune Responses in Convalescent Crimean-Congo Hemorrhagic Fever Survivors in UgandaThe Journal of Infectious Diseases · 2024
14. 658 - IMG-007, a novel nondepleting anti-OX40 monoclonal antibody with Fc bioengineering, exhibited reduced safety risks: evidence from nonclinical studiesBritish Journal of Dermatology · 2024
15. ZMapp reduces diffusion of Ebola viral particles in fresh human cervicovaginal mucusEmerging Microbes & Infections · 2024
16. Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodiesPLoS Pathogens · 2024
17. Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primatesScience Translational Medicine · 2024
18. Reconciling ultra-emitter detections from two aerial hyperspectral imaging surveys in the Permian Basin2024
19. Manipulating light for the detection of viruses in resource-limited settings2024
20. Coincident Airborne and Satellite Acquisitions of Methane Plumes2024